This review comprehensively examines the current knowledge on the relationship between body mass index (BMI) and dementia. The association between BMI and cognition is complex: in younger adults, higher BMIs are associated with impaired cognition. Overweight and obesity in middle age are linked to increased future dementia risk in old age. However, when examined in old age, higher BMIs are associated with better cognition and decreased mortality. Little is known about the optimal BMI for well-being and survival in populations already suffering from dementia. Lifetime trends in weight, rather than single measures, might predict prognosis better and help untangle these apparent contradictions. Thus, the need arises to properly monitor BMI trends in affected dementia patients. Registries can include BMI, improving the management of dementia patients throughout the whole course of the disease. The role of central obesity and systemic inflammation on brain pathology and cognitive decline are discussed in this review. Understanding the life-course changes in BMI and their influence on dementia risk, cognitive prognosis and mortality after diagnosis may provide new insights into the underlying pathophysiology of dementia and shape possible intervention and treatment strategies.
INTRODUCTION
Body mass index (BMI) is a widely-used measure of over-and underweight. Both high and low BMI are associated with mortality in most populations .1,2 In the elderly, poor nutritional status is part of the frailty syndrome, and joins a constellation of problems such as functional impairment, co-morbidity, poor cognition and psychological distress, together with their biological underpinnings and environmental factors, which are difficult to map out and address. 3 WHO (the World Health Organization) defines normal BMI as 18.5-24.9 kg/m 2 which correlates with lower morbidity among healthy young adults, 4 which is not surprising since they represent the population among which the index was originally developed. 5 Controversy exists over the BMI associated with lowest mortality among older individuals, which could lie at, or above, the overweight range of BMI as defined by the WHO (25-29.9 kg/m2). [6] [7] [8] [9] [10] The term 'obesity paradox' describes the phenomenon of excess weight presenting opposite effects on mortality risk in younger and older populations, 11 and parallels effects described with other cardiovascular risk factors in certain chronically ill populations. Most nutritional assessment tools use one BMI cut-off for all adult people; [12] [13] [14] [15] [16] [17] [18] however, higher cut-offs are suggested for older people. 19 Nevertheless, there are discrepancies between studies on the BMI associated with minimum mortality and best cognitive prognosis in different populations. [20] [21] [22] Methodological differences between studies might underlie these apparent contradictions. Since the optimal BMI might be different in different ages, studies that lump together a wide age range might fail to detect age-specific trends. 8 A similar problem might occur in studies that do not stratify by sex.
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Little is known about the optimal BMI after dementia diagnosis. Dementia causes weight loss and patients with dementia have lower BMIs than their peers. 23, 24 A reduction in BMI is associated with increased risk for dementia 25 and predates onset by at least a decade. 12, 13 Among persons with dementia, lower BMI has been associated with increased mortality risk.
14 As with older populations, the optimal BMI in dementia might lie in the overweight range, and supplementation and other nutritional interventions might have a positive effect on survival.
14 Registry studies provide an unique opportunity to answer these questions.
The aim of this review is twofold. First, to describe what is known of the influence of BMI on survival in old populations and persons suffering from dementia. Second, to support the importance of BMI on research and management of persons with dementia, and to argue for the need of including this information in registry studies.
DISCUSSION
Strengths and weaknesses of BMI BMI is the most widely employed height-to-weight ratio. BMI is a tool for gauging body shape, but says nothing about body composition and is gender, age and race specific. 15, 16 Adiposity is thought to be the main driver of the excess cardiovascular risk found in obese individuals, 17 and fat distribution is critical, with visceral fat linked to cardiovascular risk and malignancies. 17, 18 Since BMI doesn't distinguish between fat tissue and lean muscle mass, it could be a poor marker of the kind of weight excess that causes cardiovascular risk. Direct measures of body fat are preferable, with computed tomography and magnetic resonance 1 imaging volume measurements being the current gold standards, closely followed by dual-energy X-ray absorptiometry, 26 but these methods are costly and impractical. Other biometric indexes have sought to characterize body composition and fat distribution better than BMI. 17 Simple measures of waist circumference are easy to perform and have been associated with cardiovascular risk, 27 even though they do not distinguish subcutaneous fat 17 from the more metabolically active and dangerous visceral fat. Waist-hip ratio (WHR) seeks to account for subcutaneous fat 18, 27 and indeed a correlation has been described between WHR and the ratio of visceral to subcutaneous fat as measured in computed tomography. 18 Despite its limitations, BMI has a robust correlation with body fat percentage, 16 cardiovascular risk 16, 28, 29 and all-cause mortality. 20 Furthermore, BMI is the most widely-used and widelyavailable biometric index and arguably the only one in which self-measures are feasible and reliable.
BMI as a measure of nutritional status BMI is one of several indicators of risk for malnutrition and is therefore included in most screening-tools and recommendations such as Nutritional risk screening (NRS 2002), Mini Nutritional Assessment (MNA), Malnutrition University Screening Tool (MUST) and the Swedish National Board of Health and Welfare nutritional guidelines.
1 BMI, involuntary weight loss, eating difficulties, and decreased appetite must all be included in the nutritional assessment. Focus has shifted progressively to composition and an index of fat free mass index is also suggested for nutritional assessment.
Reverse epidemiology: nothing reverse about it Reverse epidemiology (RE) describes a phenomenon in which factors traditionally associated with cardiovascular risk or excess mortality among the general population present a protective effect in certain chronically or critically ill populations. This phenomenon has been observed with hypercholesterolemia, high body fat, 30 high blood pressure, serum creatinine, high parathormone and homocystein, among others. 31 Initially described among renal failure patients 32, 33, 34 it also appears in established cardiovascular disease, 30 heart failure, 35 ,36 stroke 37 chronic obstructive lung disease, 30 rheumatoid arthritis, 30 malignancies, AIDS 33 and older populations. 7, 38, 39 There is some debate as to the value of these observations and it is unclear whether RE translates an actual biological effect or results from biases or confounding.
Although the impact of cardiovascular risk factors has been less studied in dementia, the characteristics of this population make it a prime candidate for RE. Dementia presents shortened life expectancy where malnutrition is a contributing factor for death. 14, 40 Subjects with dementia present, on an average, lower BMIs than their peers and lower BMI has been correlated to increased mortality 14 and severity of cognitive impairment. 23 This indicates that a RE phenomenon could be expected among Alzheimer´s disease (AD) patients and that nutritional status and BMI need to be taken into account in epidemiological studies dealing with AD or dementia populations.
Both proponents and detractors of RE agree in substance: the conclusions should not be that high blood pressure, high cholesterol or high adiposity are beneficial 41 and neither should the treatment of cardiovascular risk factors be abandoned, although new goals might need to be developed in these groups. Rather, cardiovascular risk factors remain risk factors but their absence identifies patient subgroups which are more exposed to other, more deadly, risk factors. Hence, the course of action is not to stop treating obesity, but to identify the factors, such as malnutrition and inflammation, which are responsible for the higher mortality detected among thinner patients.
BMI, cognition and dementia risk There is a complex interplay between body weight, cognition and well-being, and this relationship could evolve over an individual's life-time. In younger subjects, higher BMI is associated with higher morbidity and mortality, 42 and could be associated with changes in brain structure and cognition. 43 In one study, metabolically normal obese young individuals displayed reductions in cortical thickness in left superior frontal and right medial orbitofrontal cortex, ventral diencephalon and brainstem volumes. 44 Obese young individuals exhibit deficits in multiple cognitive domains, such as attention, executive function and memory. Cardiovascular fitness alone cannot explain these findings: a recent study among university athletes showed BMI to be negatively correlated with verbal memory, visual memory and visual motor speed.
43 Table 1 shows an overview of studies on BMI and the risk of dementia. In middle age, higher BMI has been shown to increase the risk of dementia in later decades, 11, [45] [46] [47] [48] with some studies only finding increased dementia risk in the obese weight group, 45 while others also detect increased risk in the overweight groups. 46 One study suggested that obesity at midlife has an especially great impact on the development of vascular dementia (hazard ratio = 5,01; 95% confidence interval = 1.29-2.96), while the risk of AD was lower (HR = 3.1; 95% confidence interval = 2.19-4.38). Being overweight leads to a similar risk of both AD and vascular dementia. 46 However, low BMI and weight loss have been proposed as risk factors for the development of dementia. 47, 49 One study described increased risk of dementia death as evaluated in death certificates in underweight (BMI o20) middle-aged individuals, with a statistically non-significant trend towards increased risk also in obese individuals. 50 The end-point of dementia death, instead of diagnosis, might have accentuated the increased risk in underweight individuals and the limitations of evaluating death cause from death certificates need to be taken into account. Also relevant is the age range considered 'middleage' in all these studies which varies from 35-50, 50 40-45 46 or up to an average age of 50, 45 which might be too wide to make results comparable. However, together these studies describe a U-shaped association between BMI in middle age and future dementia risk, where the normal weight group would present minimum risk.
After middle age, a different pattern emerges. In one study, middle-aged women (38-60 years at baseline) who went on to develop dementia in older age presented a different weight pattern over their life-time than their cognitively intact peers: they experienced an attenuation in the increase in BMI experienced by their peers between the ages of 38 and 70, and after that showed parallel decline in BMI, without accelerated decline leading up to dementia onset. 51 Others describe no BMI differences between persons with dementia and controls up to 30 years before onset, but find that women who go on to develop dementia have lower BMIs than their peers 11-20 years before onset. 13 Yet another study conducted among men found that men with incident dementia experienced accentuated weight loss in the 6 years prior to diagnosis compared with non-demented subjects. 12 High BMI in older ages has been proposed as a protective factor for dementia.
11,52-54 Indeed, overweight and obese patients over 65 have demonstrated better cognitive performance than normal weight individuals in some instances. 55 It is possible that the significance of high body weight is different among the 'prematurely obese' younger individuals than among those who follow the more habitual pattern of putting on weight during middle age. However, it is hard to distinguish the effects of BMI as a possible causal factor for dementia from changes linked to preclinical disease which might begin decades before diagnosis. 56 In another study, a positive relationship was found between being overweight and AD risk among women even at older age. 57 After a dementia diagnosis, the pattern might change once again. Almost a quarter of AD patients suffer from weight loss of 4% or more in 1 year. 58 At more advanced stages of dementia the risk of malnutrition can be due to eating and swallowing difficulties. The mechanisms behind weight loss in dementia seems to be multifactorial; decreased food intake caused by inability to prepare foods or eat, impairment of olfaction and taste, and/or an increase in energy expenditure by behavior problems like agitation, restlessness and wandering, and co-morbidity. Some of these factors may be improved with structured interventions.
14 There are some potential mechanisms that could lead to weight gain in dementia population such as use of antipsychotics drugs that are known to be associated with weight increase, 59 apart from nutritional interventions. [60] [61] [62] In a recent study, BMI declined over time up to clinical onset of AD, but different patterns emerged after diagnosis, depending on baseline BMI: BMI tended to increase in underweight and normal subjects and decrease in obese patients. 63 Whether this reflects the natural evolution of the disease or the dietary interventions initiated after diagnosis is unclear. Once dementia is established, survival is worse for patients with low BMI. 14 
Gender differences
Several studies suggest differences between men and women in the impact of BMI on dementia risk. In the Gerontological and Geriatric Population Study that followed up subjects for 18 years, higher BMI has been found as a risk factor for the development of dementia in women, while in men this association was not significant. 57 A similar pattern has been observed in the Cache County Study, where BMI430 was a risk factor for the development of AD only for women. 64 Dahl et al. 53 found that high BMI in later stages of life was a protective factor for dementia. However, when the analysis was performed, separated by gender, this association was observed only in women.
Mechanisms of effect There are various mechanisms for explaining how high BMI increases the risk of dementia. Obesity is associated with several cardiovascular diseases that are related to a higher risk of dementia. 65 However, it has been shown that especially central Higher BMI is a risk factor for dementia before the age of 76 and a protective factor after 76 years BMI in dementia S García-Ptacek et al obesity is involved in this relationship, independently of diabetes and cardiovascular comorbidities. 66 Central obesity is a component of metabolic syndrome and also reflects a condition of systemic inflammation that may increase the risk for dementia. 67, 68 Inflammatory markers such as C reactive protein are increased in obese people 69 and are also associated with cognitive decline 70 and dementia. 67 Furthermore, obesity correlates with cerebral atrophy as well as white matter lesions. 71, 72 In addition, midlife obesity increases the risk of Parkinson´s disease, suggesting that there may be common mechanisms behind the link between obesity and a neurodegenerative process. 73 Once cognitive decline is established, different mechanisms might come into play and explain why individuals with lower BMIs experience worse cognition and higher mortality. 14, 51, 55, 74 Adipose tissue releases several molecules such as leptin and adiponectin, which have been found as protective compounds against the development of AD. Leptin is bound to receptors on hippocampus and has been suggested to regulate excitability of neurons, increase synaptogenesis, neurogenesis and prevent cell death induced by amyloid beta. [75] [76] [77] [78] Adiponectin is involved in modulating insulin sensitivity and additionally it has been suggested to protect against amyloid beta toxicity in AD. 79 This could explain why obesity and therefore sufficient levels of leptin and adiponectine at later stages of life are protective factors for dementia. 80 However, studies on adiponectin and leptin levels in AD patients give inconsistent results. [81] [82] [83] [84] Additional research is necessary to unveil their role in neuroprotection as they could serve as a potential strategy for preventing dementia. 85 Examining other populations in which higher BMIs are associated with lower mortality may provide some insights. RE is typically described among populations with low life expectancies, in which the effects of traditional cardiovascular risk factors might not have time to materialize, representing competing hazards. 9, 33 Furthermore, inflammation is an important component in all these conditions, and has also been linked to AD. 86 The malnutrition--inflammation complex syndrome was first described among terminal renal failure patients 32 but could also be applicable to other populations, such as heart failure, 36 and is a key factor in explaining RE observations. 87 Thus, low BMI would identify patients also suffering from inflammation, which might be the factor actually driving up mortality risk. Further study is needed to define the factors that mediate the association between BMI, cognition and mortality risk in dementia, as well as to identify possible management strategies.
CONCLUSION
There is a complex relationship between body weight, aging and cognition, and measuring nutritional status in dementia is paramount.
BMI is not without faults, but it is associated with adiposity, cardiovascular fitness, cognition and mortality. Any biometric index is better than no biometric index, and in many instances BMI is informative and sufficient.
Obesity and overweight as measured by BMI are important modifiable risk factors for dementia and AD. Evidence from observational studies seems to indicate that the relationship between BMI and mortality and BMI and cognition might be different depending on age group, sex, ethnicity and comorbidity. Most of the epidemiological studies confirm that obesity in midlife is a risk factor for the development of dementia, while high BMI in later stages of life is protective. The ongoing increase in obesity in midlife may contribute significantly to the future prevalence of dementia. Body composition and metabolic processes change with age, suggesting that the same BMI could mean very different things in an old versus a young individual. Furthermore, in the presence of certain comorbidities, lower BMI could be associated with processes that pose higher mortality risk, such as inflammation or sarcopenia. This implies that certain populations might benefit from higher BMIs than those recommended in official guidelines and that the priority among these populations is in identifying and treating the factors associated with higher mortality among the low BMI groups. Some of the discrepancies found between epidemiological studies may be the result of conflating groups with different comorbidities, disease stages and ages, in which different biological processes are predominant. BMI should not be used as a blanket measure for different populations, but rather interpreted within each group's context of health. Registry studies provide a unique opportunity for identifying BMI trends in dementia. In these, BMI follow-ups are crucial, since fluctuations in BMI might be more informative than single measures.
